跳至主要内容
临床试验/CTRI/2025/07/090154
CTRI/2025/07/090154尚未招募3 期

A Randomised Comparitive Clinical Study To Evaluate The Efficacy Of Vidangadi Loha And Punarnavadi Mandura In Panduroga Wsr To Iron Deficiency Anemia In Children

未提供1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年7月10日最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
30
试验地点
1
主要终点
Vidangadi loha may show better results in panduroga comparison to punarnavadi mandura

研究概览

简要总结

There are reasearch articles showing vidangadi loha in adult group but not in paediatric age group punarnavadi mandura is a drug which is used both in paediatric and adult group loha and mandura preparations are widely used in ayurveda to treat panduroga by considering the fact that reduced iron storage is replaced by iron itself and also ingredients of vidangadi loha have the ability to break the pathogenesis of panduroga so present study is planned to evaluate the efficacy of vidangadi loha and punarnavadi mandura in management of panduroga wsr to iron deficiency anemia in children if 4 yrs

研究设计

研究类型
Interventional

入排标准

年龄范围
4.00 Year(s) 至 5.00 Year(s)(—)
性别
All

入选标准

  • The children of age group 4 years fullfilling the diagnostic criteria Children who have taken prior written assent from his or her parent.

排除标准

  • Children having history of systemic illness which interfers the treatment Children with acute symptoms of IDA requiring blood transfusion Children with other congenital disorders related with haemopoetic system like thalassemia sickle cell anemia leukemia Children with neurobehavioral disorders like ADHD autism developmental disorders like cerebral palsy protein energy malnutrition metabolic disorders systemic infections.

结局指标

主要结局

Vidangadi loha may show better results in panduroga comparison to punarnavadi mandura

时间窗: 30 days

次要结局

  • Vidangadi loha may have better results on signs and symptoms of panduroga(30 days)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr Aiswarya s

Rajiv Gandhi University of health sciences, bengalaru

研究点 (1)

Loading locations...

相似试验